期刊文献+

银屑病的动物模型研究进展 被引量:2

Study on animal models of psoriasis
下载PDF
导出
摘要 银屑病是一种免疫异常的慢性炎症性增生性皮肤病,是由多基因遗传因素和多环境因素刺激所诱导。其组织病理学主要表现为角质形成细胞的过度增生、炎症细胞聚集和真皮乳头部血管增生扩张等,而且其皮损中多种细胞因子表达增加。这些细胞因子包括转化生长因子-α(TGF-α)、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、白介素-8(IL-8)、白介素-1(IL-1)、白介素-6(IL-6)和粒细胞巨噬细胞集落刺激因子(GM-CSF)等。为了阐明银屑病复杂的发病机制和开展药效学研究,国内外的学者探索建立了多种不同的银屑病动物模型,其中包括转基因动物模型,它们可以模拟人银屑病的某些病理特征并解释其部分病因,但是不能够反映该病的所有相关潜在因素,所以建立一个合适、理想的动物模型尤为必要。 Psoriasis is a chronic inflammatory dermatosis with immunologic abnormality and proliferation, which is induced by polygenic inheritance and muhiple environmental factors. The histological characteristics include hyperplasia of keratinocytes,aggregation of inflammatory cells, vascularization and vascular dilation of dermal papilla. In addition, there is elevated expression of many cytokines, including transforming growth factor-α (TGF-α), tumor necrosis factor-α (TNF-α), interferon-γ), ( IFN-γ), interleukin-8 ( IL -8 ), interleukin-1 ( IL-1 ), interleukin-6 ( IL-6 ) and granulocyte-macrophage colony stimulating factor (GM-CSF) ,etc. In order to study the pathogenesis and pharmacodynamies of psoriasis,various animal models have been established,including transgenic animal models, which can mimic certain aspects and partly elucidate the etiology of psoriasis. However, potential relevant factors are still elusive, thus it is necessary to establish some suitable and ideal animal models.
作者 赵香花 黄矛
出处 《药学服务与研究》 CAS CSCD 2009年第3期213-217,共5页 Pharmaceutical Care and Research
关键词 银屑病 动物模型 转基因动物 细胞因子 综述 psoriasis animal models transgenic animal cytokines review
  • 相关文献

参考文献32

  • 1Boehncke W H,Schn M P.Animal models of psoriasis[J].Clinics Dermatol,2007,25(6):596-605.
  • 2Nickoloff B J.Keratinocytes regain momentum as instigators of cutaneous inflammation[J].Trends Mol Med,2006,12(3):102-106.
  • 3Ziboh V A,Hsia S L.Effects of prostaglandin E2 on rat skin:inhibition of sterol ester biosynthesis and clearing of scaly lesions in essential fatty acid deficiency[J].J Lipid Res,1972,13(4):458-467.
  • 4Gaylarde P M,Brock A P,Sarkany I.Psoriasiform changes in guinea-pig skin from propranolol[J].Clin Exp Dermatol,1978,3(2):157-160.
  • 5van Scott E J,Bonder R H.Intravaginal and intrarectal screening of antimitotic drugs for topical effectiveness[J].J Invest Dermato1,1971,56(2):132-139.
  • 6Spearman R I C,Jarrett A.Biological comparison of isomers and chemical forms of vitamin A(retinol)[J].Br J Dermatol,1974,90(5):553-560.
  • 7Krueger G G,Manning D D,Malouf J,et al.Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice[J].J Invest Dermatol,1975,64(5):307-312.
  • 8Nickoloff B J,Kunkel S L,Burdick M,et al.Severe combined immunodeficiency mouse and human psoriatic skin chimeras.Validation of a new animal model[J].Am J Pathol,1995,146(3):580-588.
  • 9Schn M P,Detmar M,Parker C M.Murine psoriasis-like disorder induced by naive CD4+ T cells[J].Nat Med,1997,3(2):183-188.
  • 10Gilhar A,David M,Ullmann Y,et al.T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice[J].J Invest Dermatol,1997,109(3):283-288.

同被引文献26

  • 1杨京慧.银屑病病因及发病机理研究概述[J].中外医疗,2008,27(20):24-25. 被引量:7
  • 2周萌.银屑病血瘀证的思考[J].中国医学文摘(皮肤科学),2006,23(5):337-338. 被引量:8
  • 3解春桃.银屑病患者与相关细胞因子水平变化的研究[J].放射免疫学杂志,2007,20(5):414-415. 被引量:14
  • 4YARILIN D, DUAN R, HUANG Y M, et al. Dendritic cells ex-posed in vitro to TGF-31 ameliorate experimental autoimmunemyasthenia gravis [J]. Clinical and Experimental Immunology,2002,127(2): 214-219.
  • 5BRASEL K, DE S T, SMITH J L, et al. Generation of murinedendritic cells from flt3 -ligand -supplemented bone marrowcultures[J]. Blood, 2000, 96(9): 3029-3039.
  • 6PULENDRAN B, UNGAPPA J, KENNEDY UK,etd. Develop-mental pathways of dendritic cells in vivo: distinct function, phe-notype, and localization of dendritic cell subsets in FLT3 ligand-treated mice[J|. Journal of Immunology, 1997,159(5): 2222-2231.
  • 7KARSUNKY H,MERAD M, COZZIO A, et al. Flt3 ligandregulates dendritic cell development from Flt3+ lymphoid andmyeloid committed progenitors to Flt3+ dendritic cells in vivo[J].Journal of Experimental Medicine, 2003, 198(2): 305-313.
  • 8YAN H X, LI W W, ZHANG Y, et ol. Accumulation of FLT3+CDllc+ dendritic cells in psoriatic lesions and the anti-psoriaticeffect of a selective FLT3 inhibitor[J]. Immunologic Research,2014’ 60(1): 112-126.
  • 9YAN H X, WANG Y, YANG X N, et ol. A new selective vas-cular endothelial growth factor receptor 2 inhibitor ablates dis-ease in a mouse model of psoriasis[J]. Molecular Medicine Re-ports, 2013, 8(2): 434-438.
  • 10HIROTA K, DUARTE J H, YELDHOEN M, et al. Fate mapping ofinterleukin 17-producing T cells in inflammatory responses [J].Nature Immunology, 2011,12(3): 255-263.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部